vcfirmsdirectory.com

Venture capital

NeXeption Capital

NeXeption Capital is a life sciences investor-operator that forms and runs drug development companies around clinical assets, and has a fund structure launched in 2025 to finance them.

Registered · United States
New investments · 12 months
Fund vehiclesPublic
None
on the registers we read
First cheque
Active portfolio
FreeRegistry entries, fund vehicles and filingsPROEverything we enrich: deals, team, events and signals
Updated 25 Oct 2026, 02:04 CETSources: nexeption.com · SEC adviser filings

Investment activity

Round-by-round activity is part of PRO

See every round NeXeption Capital joined

Monthly deal flow, follow-ons, fund closes and exits.

Key signal this week

See all signals

Is NeXeption Capital right for your round?

Is NeXeption Capital a fit for your round?

Match your sector, round, size and region against where they invest, and see who to approach.

Key stats

Fund vehiclesPublic
None
on the registers we read
SEC adviser filings
First cheque
Core stage
New deals per year
Lead rate
Active portfolio
Exits

Fund cycle Public record

No fund vehicles on the public registers we read.

Deployed (new cheques)
Next fund expected

Latest investments

Rounds NeXeption Capital joined, from press and the firm’s own posts.

DateCompanyRoundRound sizeRoleAlongside

Every round NeXeption Capital joined

Round sizes, NeXeption Capital’s role and who invested alongside.

Round-by-round history is part of PRO

Notable portfolio

ItchBioNexEos BioUniquity BioAclaris TherapeuticsAkarna TherapeuticsCeptaris TherapeuticsCeption TherapeuticsOnspira TherapeuticsRalexar TherapeuticsTrigenesis Therapeuticsand 2 more

Portfolio and exits

Every company NeXeption Capital backed and how the exits played out.

Where the money goes

Share of companies at first investment, from the rounds we track.

Where NeXeption Capital puts its money

Sector, country and stage mix across every first cheque.

Investment team

The investment team

Partners, principals and investors, with their city, focus and how to reach them.

Where to meet NeXeption Capital

Events where NeXeption Capital’s team spoke or showed up, from event programmes, press and the firm’s own posts.

Where to meet NeXeption Capital’s partners

The events they speak at, your next chance to meet them, and which ones founders can get into.

Signals

Register and fund filings are free. Website, team and portfolio changes we pick up are PRO.

1 Oct 2026Fund filingForm ADV filed by NEXEPTION CAPITAL.SEC Form ADV · public record

Founders also look at

Frequently asked questions

NeXeption Capital is based in the United States.

The firm builds biotech companies around de-risked clinical assets, pairs them with experienced operating teams, and argues that life sciences offers large impact and high-margin returns once a drug is approved. From the firm’s own website.

NeXeption Capital lists 12 portfolio companies on its website, including ItchBio, NexEos Bio, Uniquity Bio, Aclaris Therapeutics and Akarna Therapeutics.

Firms whose websites list some of the same companies include Aperture Venture Partners, LUMIRA VENTURES and New Science Ventures.

Know before NeXeption Capital’s next round is announced.

PRO tracks NeXeption Capital’s filings, hires and portfolio changes the day they land, alongside 3,869 other firms.

NeXeption CapitalGet NeXeption Capital’s signals the day they landMonitor

Search the directory

Type a firm's name, a city or a country.